tyrphostin ag 1024 has been researched along with Colorectal Cancer in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, L | 1 |
| Li, J | 1 |
| Ran, L | 1 |
| Pan, F | 1 |
| Zhao, X | 1 |
| Ding, Z | 1 |
| Chen, Y | 1 |
| Peng, Q | 1 |
| Liang, H | 1 |
1 other study available for tyrphostin ag 1024 and Colorectal Cancer
| Article | Year |
|---|---|
Phosphorylated insulin-like growth factor 1 receptor is implicated in resistance to the cytostatic effect of gefitinib in colorectal cancer cells.
Topics: Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; | 2011 |